Part 11 Maintenance of Electronic Recs. Guidance

WITHDRAWN BY FDA Feb 2003 as not representative of their current thinking

FDA issued another 21 CFR Part 11 Draft Guidance: “Maintenance of Electronic Records”. Some may have previously referred to this as the archiving guidance. It is available at the link provided. The comment period ends Dec. 5, 2002.

This guidance first addresses basic requirements for maintaining the integrity of electronic records and signatures for the entire data retention period required in the predicate rules (Parts 820, 58, 211, etc.). Some of the topics discussed include items such retention of software, media replacement. It defines the need for procedures to address maintenance of records and discuss factors that could affect record reliability. It stresses that electronic records need to be accessible throughout the retention period not just based on frequency of usage and it mentions several times that the same types of filters, sorts, and reports should be possible throughout the time period.

It then discusses two types of approaches to records maintenance. The first is referred to as the “time capsule” approach where a system, software, and data are preserved exactly as used to create the records initially. In discussing the approach FDA expresses some doubt this approach would work long term given the rapid change in and fast obsolescence of technology and media.

The second approach is referred to as “records migration” in which records are moved from one computing environment to another. The discussion of this approach is lengthy and identifies many controls needed. One interesting statement is that an audit trail for a migrated electronic record should cover the “creation” of the new migrated record and not just that the migrated information must carry over the prior audit trail information. Another interesting area is FDA’s recognition and allowance for the fact that some data may by technical necessity change due to migration and the comments on what types of change might be acceptable if properly document.

Note that no where in the guidance does it allow for printing all the information to hard copy and retiring the electronic data and system.

 

SoftwareCPR Training Courses:

Being Agile & Yet Compliant (Public)

Our SoftwareCPR unique approach to incorporating agile and lean engineering to your medical device software process training course is now open for registration!

  • Agile principles that align well with medical
  • Backlog management
  • Agile risk management
  • Incremental and iterative software development lifecycle management
  •  Frequent release management
  • And more!

3 days virtual (Zoom) with group exercises, quizzes, examples, Q&A.

Lead Instructor: Mike Russell

Next public offerings:

  • Americas: 11-13 February 2025
  • EU/Eastern Europe/Middle East/Africa/Atlantic/eastern South America: 18-20 February 2025
  • Southern Central Northeastern Pacific: 24-26 February 2025
Register using form at this link:     Agile Course Post Promo

 

IEC 62304 and other emerging standards for Medical Device and HealthIT Software

Our flagship course for preparing regulatory, quality, engineering, operations, and others for the activities and documentation expected for IEC 62304 conformance and for FDA expectations. The goal is to educate on the intent and purpose so that the participants are able to make informed decisions in the future.  Focus is not simply what the standard says, but what is meant and discuss examples and approaches one might implement to comply.  Special deep discount pricing available to FDA attendees and other regulators.

3-days onsite with group exercises, quizzes, examples, Q&A.

Instructor: Brian Pate

Next public offering:  TBD

Call or email now to schedule a private, in-house class. The fall schedule is filling up!

Email training@softwarecpr.com to request a special pre-registration discount.  Limited number of pre-registration coupons.

Registration Link:

TBD

 


 

Medical Device Cybersecurity (Public or Private)

This course takes a deep dive into the US FDA expectations for cybersecurity activities in the product development process with central focus on the cybersecurity risk analysis process. Overall approach will be tied to relevant standards and FDA guidance documentation. The course will follow the ISO 14971:2019 framework for overall structure but utilize IEC 62304, IEC 81001-5-1, and AAMI TIR57 for specific details regarding cybersecurity planning, risk characterization, threat modeling, and control strategies.

2-days onsite with group exercises, quizzes, examples, Q&A.

Instructor: Dr Peter Rech, 2nd instructor (optional)

Next public offering:  TBD

Corporate Office

15148 Springview St.
Tampa, FL 33624
USA
+1-781-721-2921
Partners located in the US (CA, FL, MA, MN, TX) and Canada.